Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
about
Meningococcal VaccinationsAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesMonoclonal antibody therapy and renal transplantation: focus on adverse effectsComplement cascade and kidney transplantation: The rediscovery of an ancient enemyA systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Atypical Hemolytic Uremic Syndrome: A Brief Review.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Meningococcal disease and the complement system.Central nervous system syndromes in solid organ transplant recipients.Immunization after kidney transplantation-what is necessary and what is safe?Advances in pharmacotherapy to treat kidney transplant rejection.Complement inhibition as potential new therapy for antibody-mediated rejection.An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment.Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed.A Case of Fulminant Meningococcemia: It Is All in the Complement.Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies.Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.Vaccinations in children on immunosuppressive medications for renal disease.Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.Thrombotic Microangiopathy and the Kidney.Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations.
P2860
Q26752993-A7445CE5-FDC7-4912-ABBC-1C276AAFFA3EQ26796453-C37B1844-4E94-4712-8FCB-AE6DEF8FF45BQ26826880-1B75C09B-07C1-4EA2-BE87-BB46BC208708Q26829790-58719DAE-5E65-4077-8237-61CC76D07D39Q28661698-1550AD4F-AEA2-49A1-AD50-1427E935F887Q33417375-6C49760F-61F5-4980-B22B-65A769B80EF8Q33421861-1EE9DD87-C508-49CC-B0BB-3F170078B933Q33430681-CBF52A61-2023-4A0B-839D-0C46728A5433Q33430817-75B3A875-778A-49A1-B22E-8D3B36E8AB56Q33442794-3BA44D39-B52B-4698-9517-B794BAD8F25AQ33783126-57EEC337-570F-467A-8940-D7E1C1362438Q34376170-D2BACC7A-5E92-4F10-8945-4C453BB8C57CQ38219391-32091C30-61EE-4B2B-98D6-65727179BFD9Q38235003-B8D9C30C-00D9-40D0-8691-0A1F692469B6Q38544529-5A3C53F9-75E6-4C72-BE46-74AE44F25783Q38609238-F5E6B204-31FC-44D5-A37C-2A3EFB43A2F1Q38775024-93CB9B62-C49E-4B5F-B741-D970AB6AE349Q38806679-4104F6ED-E28E-48A8-86FA-E5D5F201109CQ38907049-E195840E-6AFD-4E04-A5FB-B94801BEA7EDQ38998217-772BB65B-62EC-40D7-A0A1-21DC6B06DD7CQ40093163-404C4F2A-0199-4A32-9505-7B0FA2D61429Q40268126-DEAA482E-F6AA-4278-9251-2FC0162C47F0Q40722182-2C197DD4-FD86-436A-A4C0-97AA0F5A9FCEQ40960257-1CF54F7A-38C0-46D9-A94A-CF85DCE7E4A4Q41488993-CF2829BD-91BF-439F-9F3A-E7FD159F38FBQ42086661-1122DFA2-DC66-4E0E-9837-D38E5F62AED8Q48255838-AA952BE5-9B09-4A2B-9E47-F8B3B949DB26Q50085453-DEB57296-E1E0-4F25-AB65-C1395D024AFCQ54432568-7A1FB66C-2335-4DC5-9387-629F492D5BEEQ55505646-111F30AF-A9A8-43B1-8DD0-92BEA612891E
P2860
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@en
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@nl
type
label
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@en
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@nl
prefLabel
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@en
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@nl
P2093
P2860
P356
P1476
Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.
@en
P2093
A H M Bouts
E A C Kuin
F J Bemelman
G H Struijk
G T Rijkers
I J M ten Berge
P2860
P304
P356
10.1111/AJT.12032
P407
P577
2013-01-07T00:00:00Z